Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors: Impact on Intestinal Microbiota and in Clinical Outcomes

NCT03727113 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT03727113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03727113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors: Impact on Intestinal Microbiota and in Clinical Outcomes
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Observational
Overall status
Completed
Start date
January 16, 2018
Completion date
June 30, 2021
Enrollment
211 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease, hematopoietic stem cell transplantation